Shire faces reverse-payment lawsuit over ADHD medication
Credit: iStock/mik38
An independent South Carolina pharmacy has filed a class action complaint against Shire for entering into an agreement with Actavis to allegedly keep a generic version of its brand-name attention deficit hyperactivity disorder medication off the market.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10